Trial Profile
A Phase I, Open-Label, Randomized, Four Period Crossover Drug Interaction Study to Evaluate the Pharmacokinetic Profiles of VYVANSE and ADDERALL XR When Each is Administered Alone and in Combination With the Proton Pump Inhibitor Prilosec OTC in Healthy Adult Volunteers.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 16 Jun 2021
Price :
$35
*
At a glance
- Drugs Lisdexamfetamine (Primary) ; Mixed amfetamine salts (Primary) ; Omeprazole
- Indications Affective disorders; Gastrointestinal disorders
- Focus Pharmacokinetics
- Sponsors Shire
- 19 Jun 2009 Additional lead trial investigator identified as reported by ClinicalTrials.gov.
- 22 May 2009 Results were announed in a Shire media release.
- 28 Apr 2009 Results were presented at the International Congress on Clinical Pharmacy, according to a Shire media release.